These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2696879)

  • 1. [Occult carcinoma of the breast presenting as an axillary node enlargement].
    Murai H; Yoshida M; Miura S
    Nihon Geka Gakkai Zasshi; 1989 Dec; 90(12):2015-20. PubMed ID: 2696879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical benefits of mastectomy on treatment of occult breast carcinoma presenting axillary metastases.
    Wang X; Zhao Y; Cao X
    Breast J; 2010; 16(1):32-7. PubMed ID: 20465598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis.
    Varadarajan R; Edge SB; Yu J; Watroba N; Janarthanan BR
    Oncology; 2006; 71(5-6):456-9. PubMed ID: 17690561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occult breast carcinoma presenting as an axillary mass.
    Scoggins CR; Vitola JV; Sandler MP; Atkinson JB; Frexes-Steed M
    Am Surg; 1999 Jan; 65(1):1-5. PubMed ID: 9915521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
    Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N
    Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
    Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
    Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metachronous secondary primary occult breast cancer initially presenting with metastases to the contralateral axillary lymph nodes: report of a case.
    Kinoshita S; Hirano A; Kobayashi S; Komine K; Kyoda S; Takeyama H; Uchida K; Morikawa T; Nagase J; Sakamoto G
    Breast Cancer; 2010; 17(1):71-4. PubMed ID: 19259764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance?
    Salama JK; Heimann R; Lin F; Mehta N; Chmura SJ; Singh R; Kao J
    Cancer; 2005 Feb; 103(4):664-71. PubMed ID: 15641038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary lymph node metastases as the sole clinical site of occult breast carcinoma.
    Dragoumis DM; Tsiftsoglou AP; Sikou AD; Assimaki AS
    J Coll Physicians Surg Pak; 2008 Aug; 18(8):517-9. PubMed ID: 18798593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult metastases in axillary lymph nodes as a predictor of survival in node-negative breast carcinoma with long-term follow-up.
    Reed W; Bøhler PJ; Sandstad B; Nesland JM
    Breast J; 2004; 10(3):174-80. PubMed ID: 15125740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
    Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
    Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year survival of 100 women with carcinoma of the breast diagnosed by screening mammography and needle-localization biopsy.
    Bauer TL; Pandelidis SM; Rhoads JE
    J Am Coll Surg; 1994 May; 178(5):427-30. PubMed ID: 8167877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields.
    Yu J; Li G; Li J; Wang Y
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):874-8. PubMed ID: 15708269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study.
    Dowlatshahi K; Fan M; Bloom KJ; Spitz DJ; Patel S; Snider HC
    Cancer; 1999 Sep; 86(6):990-6. PubMed ID: 10491525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical analysis of seven patients with occult breast cancer and literature reviews].
    Yu H; Yang MT; Rong TH; Long H; Ou W
    Ai Zheng; 2002 May; 21(5):541-3. PubMed ID: 12452050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult breast cancer presenting as axillary metastases.
    Yamaguchi H; Ishikawa M; Hatanaka K; Uekusa T; Ishimaru M; Nagawa H
    Breast; 2006 Apr; 15(2):259-62. PubMed ID: 15996865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omitting axillary lymph node dissection in sentinel node negative breast cancer patients is safe: a long term follow-up analysis.
    Torrenga H; Fabry H; van der Sijp JR; van Diest PJ; Pijpers R; Meijer S
    J Surg Oncol; 2004 Oct; 88(1):4-7; discussion 7-8. PubMed ID: 15384064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of occult metastatic lobular carcinoma in axillary lymph nodes using anticytokeratin monoclonal antibodies.
    Lachman MF; Ricci A; Pedersen CA; Cartun RW; Strumpf KB
    Conn Med; 1992 Feb; 56(2):65-8. PubMed ID: 1373112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.